Payali, Noradja .
HRN: 16 17 82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2022
METRONIDAZOLE 500MG (TAB)
07/26/2022
08/02/2022
PO
500mg
TID X 7 Days
UTI; G5P4 (4002) Pregnancy Uterine
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes